scholarly journals Prevention of post endoscopic retrograde cholangiopancreatography pancreatitis

2012 ◽  
Vol 03 (S 05) ◽  
pp. 068-070 ◽  
Author(s):  
Nalini M. Guda

AbstractPost ERCP pancreatitis (PEP) is a common problem. Knowledge of patient and procedure related risk factors along with appropriate measures aimed at reduction of risk have been successful in reducing both the incidence and the severity. Prophylactic pancreatic duct stenting has definitely reduced the incidence and the severity of PEP in high risk patients. There are some emerging data on the use of non steroidal anti inflammatory agents though this is not widely adapted in practice. Key is to avoid procedures with marginal indications and use of non invasive/less invasive procedures.

2011 ◽  
Vol 50 (24) ◽  
pp. 2927-2932 ◽  
Author(s):  
Kei Ito ◽  
Naotaka Fujita ◽  
Atsushi Kanno ◽  
Hiroyuki Matsubayashi ◽  
Shinji Okaniwa ◽  
...  

2015 ◽  
Vol 4 (2) ◽  
pp. 67-71
Author(s):  
Hossein Ajdarkosh ◽  
Gholamreza Hemasi ◽  
Farhad Zamani ◽  
Masoudreza Sohrabi ◽  
Mohammad Mahdi Zamani ◽  
...  

Background: Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography (ERCP). Several medical and surgical procedures have been analyzed in prevention of post-ERCP pancreatitis as a major post-ERCP complication, so we conducted a study to assess the role of prophylactic pancreatic stents on prevention and severity of post-ERCP pancreatitis. Materials and Methods: This case control studied adult patients undergoing ERCP at the ERCP unit of a referral educational hospital. Data of the case (stent, N=90) and control (non-stent) (N=105) groups were retrieved from medical records. In our center, sphinctrerotomy was performed for 103 patients of non-stent group and successful pancreatic stent placement was done in 86 patients of stent group in a standard fashion. In stent group, a 5F, 4 centimeter pancreatic stent was emplaced over a guide wire under fluoroscopic guidance. All post–ERCP pancreatitis and major complications of all patients were retrieved too. Results: Of 255 enrolled patients, 195 were at high risk of post-ERCP pancreatitis allocated in two groups of this study. Successful pancreatic stent placement was done in 86 patients (95.6%) of stent group. There was no major complication during procedures. The migration of pancreatic duct stent was diagnostic in 3 (3.5%) patients. The overall post ERCP pancreatitis was 4.0% and 16.6% in stent and non-stent groups, respectively. Conclusion: Based on our findings in this study, we strongly recommended pancreatic duct stent placement in high-risk patients; although the experience of endoscopist plays a crucial role. [GMJ.2015;4(2):67-71]


Sign in / Sign up

Export Citation Format

Share Document